Prednisone Shot is Not Recommended for Severe Psoriasis in Older Adults
Prednisone shots are not recommended for the treatment of severe psoriasis in older adults due to poor long-term efficacy and significant safety concerns. 1
Why Prednisone Should Be Avoided
- Systemic corticosteroids like prednisone are not mentioned in any of the current treatment guidelines for psoriasis management, indicating they are not considered standard of care 1
- Corticosteroid withdrawal can trigger severe psoriasis flares or even pustular psoriasis when discontinued 1
- Older adults are particularly vulnerable to adverse effects of systemic corticosteroids, including:
Recommended First-Line Treatments for Severe Psoriasis in Older Adults
- High-potency topical corticosteroids (class 1-3) are recommended for initial management of localized psoriasis for up to 4 weeks 1, 5
- Examples include clobetasol propionate 0.05%, betamethasone dipropionate 0.05%, and fluocinonide 0.05% 1
- Combination therapy with topical vitamin D analogues (calcipotriene) plus corticosteroids provides superior efficacy compared to either agent alone 1, 5
Recommended Systemic Treatments for Severe Psoriasis in Older Adults
- Biologic agents are the preferred systemic treatment for severe psoriasis in older adults who have failed topical therapy 1, 3
- The most effective biologics for achieving PASI 90 (90% improvement) in order of effectiveness are:
Special Considerations for Older Adults
- Comprehensive evaluation of comorbidities and concomitant medications is essential before initiating any systemic therapy 3, 4
- More frequent monitoring of laboratory parameters is recommended in older adults on systemic therapies 3
- Despite proven safety and efficacy, biologic agents are used approximately half as frequently in older adults compared to younger patients 4
- Age alone should not be a limiting factor in psoriasis management decisions 3
Treatment Algorithm for Severe Psoriasis in Older Adults
- First step: High-potency topical corticosteroids with or without vitamin D analogues 1, 5
- If inadequate response: Consider phototherapy (narrowband UVB) as second-line treatment 7, 8
- For moderate-to-severe disease unresponsive to above:
- Consider biologics based on comorbidity profile 1, 3
- TNF-α inhibitors should be avoided in patients with heart failure, demyelinating disease, or recurrent infections 1
- IL-17 inhibitors should be avoided in patients with inflammatory bowel disease 1
- IL-12/23 inhibitors (ustekinumab) or IL-23 inhibitors may be preferred in older adults due to less frequent dosing and favorable safety profile 1, 3
Common Pitfalls to Avoid
- Avoid systemic corticosteroids like prednisone shots for psoriasis management in any age group, but especially older adults 2, 3
- Do not undertreat severe psoriasis in older adults due to age-related concerns; effective treatment options exist 3, 4
- Carefully monitor for drug interactions when initiating any systemic therapy in older adults 4
- Ensure appropriate dosing adjustments based on renal function, which commonly declines with age 3